BeStock  
Markets › Compare › SHTDY vs ARWR

SHTDY vs ARWR

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
SHTDY · SINOPHARM GROUP CO$10.65 ▼ 0.47%
ARWR · Arrowhead Pharmaceuticals$41.37 ▼ 5.22%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

68103139174210Nov 24, '25May 26, '26Nov 20, '26
  • SHTDY -14.2%
  • ARWR -6.5%

Head to head

MetricSHTDYARWR
Price$10.65$41.37
Change today▼ 0.47%▼ 5.22%
Market cap$5.84B$5.85B
Return, 3 months+2.8%-52.3%
Return, year to date-9.7%-37.7%
Return, 1 year-13.4%+2.3%
P/E (TTM)6.6–
P/B0.5116.2
P/E percentile vs own 5y–73rd
Dividend yield4.72%–
Revenue growth (YoY, latest qtr)–-85.3%
Net profit growth (YoY)–-2,760.4%
Gross margin–99.6%
Operating margin–-156.9%
Net margin–-160.6%
Return on equity–-280.5%
Analyst target vs. price–+157.7%
Analyst buy share–91%
RSI (14)5821
30-day volatility24.2%64.5%
Max drawdown, 1 year-30.2%-53.8%
Trend readLeaning bullishStrong downtrend
Analyst consensus–Buy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ARWR is the largest of the group by market value.
  • ARWR has returned the most over the past year.
  • SHTDY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top